يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Antihypertensive Agents administration & dosage"', وقت الاستعلام: 1.56s تنقيح النتائج
  1. 1

    المصدر: BMC cardiovascular disorders, vol. 17, no. 1, pp. 177
    BMC Cardiovascular Disorders, Vol. 17, No 1 (2017) P. 177
    BMC Cardiovascular Disorders
    BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-9 (2017)

    مصطلحات موضوعية: Male, lcsh:Diseases of the circulatory (Cardiovascular) system, Time Factors, Vasodilator Agents, Down syndrome, Cardiac index, Administration, Oral, 030204 cardiovascular system & hematology, chemistry.chemical_compound, 0302 clinical medicine, 030212 general & internal medicine, Pulmonary Artery/drug effects/physiopathology, Child, Children, education.field_of_study, ddc:618, Arterial Pressure/drug effects, Cardiac surgery, Treatment Outcome, Vasodilator Agents/administration & dosage/adverse effects, Adolescent, Antihypertensive Agents/administration & dosage, Antihypertensive Agents/adverse effects, Child, Preschool, China, Down Syndrome/complications, Down Syndrome/diagnosis, Female, Humans, Hypertension, Pulmonary/diagnosis, Hypertension, Pulmonary/drug therapy, Hypertension, Pulmonary/etiology, Hypertension, Pulmonary/physiopathology, Infant, Pulmonary Artery/drug effects, Pulmonary Artery/physiopathology, Sildenafil Citrate/administration & dosage, Sildenafil Citrate/adverse effects, Vascular Resistance/drug effects, Vasodilator Agents/administration & dosage, Vasodilator Agents/adverse effects, Pulmonary hypertension, Sildenafil, Administration, Hypertension, Cardiology, cardiovascular system, Cardiology and Cardiovascular Medicine, Research Article, Oral, medicine.medical_specialty, Hypertension, Pulmonary, Population, Pulmonary Artery, Placebo, Sildenafil Citrate, 03 medical and health sciences, Internal medicine, medicine, Sildenafil Citrate/administration & dosage/adverse effects, Arterial Pressure, education, Preschool, Antihypertensive Agents, Angiology, business.industry, Pulmonary/diagnosis/drug therapy/etiology/physiopathology, medicine.disease, Down Syndrome/complications/diagnosis, respiratory tract diseases, chemistry, lcsh:RC666-701, Vascular Resistance, Antihypertensive Agents/administration & dosage/adverse effects, business

    وصف الملف: application/pdf

  2. 2

    المساهمون: The George Institute for Global Health [Sydney] (GIGH), The University of Sydney, Royal Prince Alfred Hospital (RPAH - SYDNEY), Department of Cardiovascular Sciences [Leicester], University of Leicester, Department of Neurology (Dep Neuro - Peking Hospital - BEIJING), Peking University [Beijing], Stroke Program and Department of Epidemiology (Stroke Program - ANN ARBOR), University of Michigan [Ann Arbor], University of Michigan System-University of Michigan System, Deparment of Neurology (LARIBOISIERE - Neurologie), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Department of Neurology (Dep Neuro - HEBEI PROVINCE), Yutian County Hospital, CIC Brest, Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital de la Cavale Blanche, Service de Neurologie [Brest], Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Neurology, Clinical sciences, Neuroprotection & Neuromodulation, Supporting clinical sciences, UZB Other, Physical Medicine and Rehabilitation, Vriendenkring VUB

    المصدر: Cerebrovascular Diseases, 40, 3-4, pp. 114-20
    Sato, Shoichiro; Arima, Hisatomi; Heeley, Emma; Hirakawa, Yoichiro; Delcourt, Candice; Lindley, Richard I; Robinson, Thompson; Huang, Yining; Morgenstern, Lewis; Stapf, Christian; Wang, Jiguang; Chalmers, John; Anderson, Craig S; INTERACT2, Investigators; Fischer, Urs; Arnold, Marcel (2015). Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial. Cerebrovascular diseases, 40(3-4), pp. 114-120. Karger 10.1159/000434690 <http://dx.doi.org/10.1159/000434690>
    Cerebrovascular Diseases, 40, 114-20
    Cerebrovascular Diseases
    Cerebrovascular Diseases, Karger, 2014, 40 (3-4), pp.114-20. ⟨10.1159/000434690⟩

    وصف الملف: application/pdf

  3. 3
  4. 4

    المساهمون: Neurology, Clinical sciences, Neuroprotection & Neuromodulation, The Georges Institute for International Health, The University of Sydney, Neurology Department (RPA Hospital - Neurology), Royal Prince Alfred Hospital, Department of Neurology, Xuanwu Hospital of Capital-University of Medical Sciences / Beijing, Centre for Epidemiological Studies and Clinical Trials, Shanghai Jiao Tong University School of Medicine-Ruijin Hospital, Deparment of Neurology (LARIBOISIERE - Neurologie), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Neurology Department (RPH Hospital - Neurology), Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, University of Leicester, Servicio de Neurologia (SANTIAGO - Neurologie), Universidad del Desarrollo, Department of Neurology (JH Hospital - Neurology), University of Newcastle [Australia] (UoN), Department of Neurology (BOATOU - Neurology), Boatou Central Hospital, Department of Neurology (TANGSHAN - Neurology), Yutian County Hospital, National Health and Medical Research Council Clinical Trials Centre, Melbourne Brain Centre (Melbourne Brain Centre), University of Melbourne

    المصدر: Anderson, Craig S.; Heeley, Emma; Huang, Yining; Wang, Jiguang; Stapf, Christian; Delcourt, Candice; Lindley, Richard; Robinson, Thompson; Lavados, Pablo; Neal, Bruce; Hata, Jun; Arima, Hisatomi; Parsons, Mark; Li, Yuechun; Wang, Jinchao; Heritier, Stephane; Li, Qiang; Woodward, Mark; Simes, R. John; Davis, Stephen M.; ... (2013). Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage. New England journal of medicine NEJM, 368(25), pp. 2355-2365. Massachusetts Medical Society MMS 10.1056/NEJMoa1214609 <http://dx.doi.org/10.1056/NEJMoa1214609>
    New England Journal of Medicine
    New England Journal of Medicine, Massachusetts Medical Society, 2013, 368 (25), pp.2355-65. ⟨10.1056/NEJMoa1214609⟩

    وصف الملف: application/pdf

  5. 5

    المصدر: Swiss medical weekly, vol. 136, no. 21-22, pp. 346-352
    Scopus-Elsevier

    وصف الملف: application/pdf

  6. 6

    المساهمون: Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de médecine générale [Université de Nantes - UFR de Médecine et des Techniques Médicales] (DMG Nantes), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Service Pharmacologie Clinique [CHU Toulouse], Pôle Santé publique et médecine publique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université Toulouse III Paul Sabatier - Faculté de médecine Purpan (UTPS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, NantesU M, Dépôt

    المصدر: PLoS ONE
    PLoS ONE, 2012, 7 (3), pp.e34187. ⟨10.1371/journal.pone.0034187⟩
    PLoS ONE, Vol 7, Iss 3, p e34187 (2012)

    مصطلحات موضوعية: Male, Time Factors, Hyperkalemia, Epidemiology, [SDV]Life Sciences [q-bio], medicine.medical_treatment, lcsh:Medicine, Angiotensin-Converting Enzyme Inhibitors, Pharmacology, Cardiovascular, Cohort Studies, chemistry.chemical_compound, Drug Interactions, Renal Insufficiency, Practice Patterns, Physicians', lcsh:Science, Diuretics, Aged, 80 and over, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Multidisciplinary, medicine.diagnostic_test, Anti-Inflammatory Agents, Non-Steroidal, Middle Aged, [SDV] Life Sciences [q-bio], Treatment Outcome, Creatinine, Medicine, Female, Public Health, France, medicine.symptom, MESH: Aged Aged, 80 and over Angiotensin Receptor Antagonists / administration & dosage* Angiotensin-Converting Enzyme Inhibitors / administration & dosage* Anti-Inflammatory Agents, Non-Steroidal / administration & dosage* Anti-Inflammatory Agents, Non-Steroidal / adverse effects Antihypertensive Agents / administration & dosage* Antihypertensive Agents / adverse effects Cohort Studies Creatinine / blood Diuretics / administration & dosage Drug Interactions* Female France Humans Hyperkalemia / chemically induced Insurance Claim Review Male Middle Aged Potassium / blood Practice Patterns, Physicians' Renal Insufficiency / chemically induced Retrospective Studies Time Factors Treatment Outcome, Research Article, medicine.drug, Drugs and Devices, medicine.medical_specialty, Clinical Research Design, Piroxicam, Angiotensin Receptor Antagonists, Insurance Claim Review, Pharmacotherapy, Diclofenac, Internal medicine, medicine, Humans, cardiovascular diseases, Primary Care, Antihypertensive Agents, Aged, Retrospective Studies, business.industry, lcsh:R, Immunity, Retrospective cohort study, chemistry, Therapeutic drug monitoring, Potassium, Women's Health, lcsh:Q, Clinical Immunology, Diuretic, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

  7. 7

    المصدر: Respiratory Research
    Respiratory Research, Vol. 12 (2011) P. 58
    Respiratory Research, Vol 12, Iss 1, p 58 (2011)

    مصطلحات موضوعية: Endothelin Receptor Antagonists, Male, Time Factors, Pyridines, Bronchoconstriction/drug effects, Vasodilator Agents, Vasoactive intestinal peptide, Airway Resistance/drug effects, Phosphodiesterase 5 Inhibitors/pharmacology, Administration, Oral, Tetrazoles, Blood Pressure, Piperazines, Endothelins, Rats, Sprague-Dawley, Receptors, Endothelin/antagonists & inhibitors/metabolism, Signal Transduction/drug effects, Hypertension, Pulmonary/complications/drug therapy/metabolism/physiopathology, Infusions, Parenteral, Vasoactive Intestinal Peptide/pharmacology, Sulfones, Piperazines/pharmacology, Lung, Pyridines/pharmacology, ddc:618, ddc:617, Receptors, Endothelin, Infusion Pumps, Implantable, respiratory system, Iloprost/pharmacology, medicine.anatomical_structure, Bronchial hyperresponsiveness, Cardiology, Lung/blood supply/drug effects/metabolism/physiopathology, Bronchial Hyperreactivity, Lung Volume Measurements, Purines/pharmacology, medicine.drug, Signal Transduction, Vasoactive Intestinal Peptide, medicine.hormone, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Bronchoconstriction, Hypertension, Pulmonary, Bronchial Hyperreactivity/etiology/metabolism/physiopathology/therapy, Nitric Oxide, Blood Pressure/drug effects, Bronchial Provocation Tests, Sildenafil Citrate, Internal medicine, medicine, Animals, Prostaglandins I, Antihypertensive Agents/administration & dosage/pharmacology, Iloprost, Vasodilator Agents/administration & dosage/pharmacology, Antihypertensive Agents, lcsh:RC705-779, Analysis of Variance, business.industry, Research, Airway Resistance, lcsh:Diseases of the respiratory system, Phosphodiesterase 5 Inhibitors, medicine.disease, Endothelins/metabolism, Angiotensin II, Pulmonary hypertension, Sulfones/pharmacology, Tetrazoles/pharmacology, Rats, Prostaglandins I/metabolism, Disease Models, Animal, Endocrinology, Purines, Nitric Oxide/metabolism, Methacholine, business

  8. 8
    دورية أكاديمية